Sector Lead, Biotech Private Investments
Current
Dec 2024 - Present
AeroLeads people directory · profile
Jason Ruth Email & Phone Number
Biotech Private Investments
at
Wellington Management
1 work email found
@5amventures.com
2 phones found area 215
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Biotech Private Investments
Location
Cambridge, Massachusetts, United States
Who is Jason Ruth? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Jason Ruth is listed as Biotech Private Investments at Wellington Management, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at 5amventures.com, phone signal with area code 215, and a matched LinkedIn profile for Jason Ruth.
Jason Ruth previously worked as Sector Lead, Biotech Private Investments at Wellington Management and Partner, MRL Ventures Fund at Merck. Jason Ruth holds Phd, Bioengineering, Hhmi-Nibib Scholar from University Of Pennsylvania School Of Medicine.
Company email context
Email format at Wellington Management
This section adds company-level context without repeating Jason Ruth's masked contact details.
{first}@5amventures.com
86% confidence
AeroLeads found 1 current-domain work email signal for Jason Ruth. Compare company email patterns before reaching out.
Profile bio
About Jason Ruth
Jason Ruth is a Biotech Private Investments at Wellington Management. He possess expertise in biomedical engineering, cancer research, molecular biology, tissue culture, spectroscopy and 26 more skills.
Listed skills include Biomedical Engineering, Cancer Research, Molecular Biology, Tissue Culture, and 27 others.
Current workplace
Jason Ruth's current company
Company context helps verify the profile and gives searchers a useful next step.
15 roles · 26 years
Jason Ruth work experience
A career timeline built from the work history available for this profile.
Partner, Mrl Ventures Fund
- Led investments in Series As for Aktis Oncology, Ray Therapeutics.- Board Observer roles with Aktis Oncology, Ray Therapeutics, LifeMine Therapeutics.
May 2022 - Dec 2024
Principal
Late stage private and public investing:- Led investments in, Disc Medicine (NASDAQ: IRON), Janux Therapeutics (NASDAQ: JANX), and Avidity Biosciences (NASDAQ: RNA).
Jul 2020 - May 2022
Senior Associate
Venture capital and venture creation:- Cabaletta Bio (NASDAQ: CABA): Led Series A investment, Board Observer.- Entrada Therapeutics (NASDAQ: TRDA): Co-led Seed and Series A investments, co-inventor on patent and company building through part-time operational role, Board Observer.- Vor Biopharma (NASDAQ: VOR): Co-led Series A investment, company building.
Jan 2019 - Jun 2020
Associate
Jan 2017 - Dec 2018
Board Observer
- 5AM founded Expansion Therapeutics and led the $55M Series A investment.- Expansion Therapeutics, founded by 5AM Ventures and Matt Disney from The Scripps Research Institute, is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases.
Apr 2017 - Sep 2021
Board Observer
- Previously a Board Observer for Entrada Therapeutics (NASDAQ: TRDA).- Interim operations role during seed, co-inventor on patent.- 5AM founded Entrada Therapeutics and led the $59M Series A investment.- Entrada Therapeutics, founded by 5AM Ventures and Dehua Pei from OSU, is a biotechnology company dedicated to transforming the treatment of devastating.
Mar 2017 - Mar 2021
Board Observer
- Previously a Board Observer with Vor Biopharma (NASDAQ:VOR).- 5AM led $42M Series A investment.- Vor Biopharma is an immuno-oncology company developing edited stem cell therapies that can enable selective targeting of cancer cells without impacting normal cells.
Feb 2019 - Jan 2021
Board Observer
- Previously a Board Observer with Cabaletta Bio (NASDAQ:CABA).- 5AM led $38M Series A and participated in $50M Series B investments.- Cabaletta is a biopharmaceutical company focused on the discovery and development of T cell therapies for B cell-mediated autoimmune diseases.
Oct 2018 - Oct 2019
Board Observer
Homology Medicines, Inc.
- Previously a Board Observer with Homology Medicines (NASDAQ:FIXX).- Homology Medicines, founded by 5AM Ventures and Saswati Chatterjee from City of Hope, is a genetic medicines company translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Mar 2017 - Mar 2018
Postdoctoral Research Fellow
Sep 2014 - Dec 2016
Postdoctoral Research Fellow
Postdoctoral Research Fellow in Levi Garraway's laboratory- Co-first author publication in Science: Discovered mechanistic basis for PRMT5 depenedency in MTAP null cancers, providing the initial rationale for development of MTA-cooperative PRMT5 inhibitors.- Co-inventor on patent for "Selective treatment of prmt5 dependent cancer"- Started course in.
Sep 2014 - Dec 2016
Phd In Bioengineering
PhD in Bioengineering from Lewis Chodosh's Laboratory, Dept. Cancer Biology- Coursework: Medical school curriculum plus graduate bioengineering courses.- HHMI-NIBIB Interfaces Fellowship, 1 of 3 PhD students awarded at UPenn in 2008.- NCI F31 Kirschstein Predoctoral Fellowship to investigate cancer immunology.- Awarded Best Presentation at 2014 Department.
Aug 2008 - Aug 2014
Ucleads Research Scholar And Research Technician
UCLEADS Research Scholar in Bruce Tromberg's Laboratory, Dept. Biomedical Engineering- Awarded UCLEADS research scholarship, 1 of 9 undergraduates awarded at UC Irvine in 2005.
2005 - 2008
~3 yrs
Carpenter'S Apprentice
Doors And Finish
3 takeaways from working summers and holidays in the family business as a teenager:1. Start early2. Surpass expectations3. Live by your core values
2000 - 2004
~4 yrs
2 education records
Jason Ruth education
Phd, Bioengineering, Hhmi-Nibib Scholar
University Of Pennsylvania School Of Medicine
Bs, Biomedical Engineering, Ucleads Scholar
Uc Irvine
FAQ
Frequently asked questions about Jason Ruth
Quick answers generated from the profile data available on this page.
What company does Jason Ruth work for?
Jason Ruth works for Wellington Management.
What is Jason Ruth's role at Wellington Management?
Jason Ruth is listed as Biotech Private Investments at Wellington Management.
What is Jason Ruth's email address?
AeroLeads has found 1 work email signal at @5amventures.com for Jason Ruth at Wellington Management.
What is Jason Ruth's phone number?
AeroLeads has found 2 phone signal(s) with area code 215 for Jason Ruth at Wellington Management.
Where is Jason Ruth based?
Jason Ruth is based in Cambridge, Massachusetts, United States while working with Wellington Management.
What companies has Jason Ruth worked for?
Jason Ruth has worked for Wellington Management, Merck, 5Am Ventures, Expansion Therapeutics, and Entrada Therapeutics.
How can I contact Jason Ruth?
You can use AeroLeads to view verified contact signals for Jason Ruth at Wellington Management, including work email, phone, and LinkedIn data when available.
What schools did Jason Ruth attend?
Jason Ruth holds Phd, Bioengineering, Hhmi-Nibib Scholar from University Of Pennsylvania School Of Medicine.
What skills is Jason Ruth known for?
Jason Ruth is listed with skills including Biomedical Engineering, Cancer Research, Molecular Biology, Tissue Culture, Spectroscopy, Cancer, Image Analysis, and Animal Models.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial